Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;8(s1):S47-S51.
doi: 10.3233/JPD-181482.

The Future of Brain Imaging in Parkinson's Disease

Rick C Helmich  1 , David E Vaillancourt  2 , David J Brooks  3
Affiliations
Review

The Future of Brain Imaging in Parkinson's Disease

Rick C Helmich et al. J Parkinsons Dis. 2018.

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder that is associated with distinct abnormalities in brain function and structure. Here we discuss how future developments in functional, structural and nuclear brain imaging may help us to better understand, diagnose, and potentially even treat PD. These new horizons may be reached by developing tracers that specifically bind to alpha synuclein, by looking into different places in the body (such as the gut) or in smaller cerebral nuclei (with improved spatial resolution), and by developing new approaches for quantifying and interpreting altered dynamics in large-scale brain networks.

Keywords: Parkinson’s disease; biomarkers; magnetic resonance imaging; neuroimaging; positron emission tomography.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Potential new imaging methods in Parkinson’s disease. This figure schematically represents new approaches for functional magnetic resonance imaging (fMRI), structural MRI, and positron emission tomography (PET) imaging.
See this image and copyright information in PMC

References

    1. Helmich RC (2018) The cerebral basis of Parkinsonian tremor: A network perspective. Mov Disord 33, 219–231. - PubMed
    1. Schindlbeck KA, Eidelberg D (2018) Network imaging biomarkers: Insights and clinical applications in Parkinson’s disease. Lancet Neurol 17, 629–640. - PubMed
    1. Kim J, Criaud M, Cho SS, Diez-Cirarda M, Mihaescu A, Coakeley S, Ghadery C, Valli M, Jacobs MF, Houle S, Strafella AP (2017) Abnormal intrinsic brain functional network dynamics in Parkinson’s disease. Brain 140, 2955–2967. - PMC - PubMed
    1. Stephan KE, Schlagenhauf F, Huys QJM, Raman S, Aponte EA, Brodersen KH, Rigoux L, Moran RJ, Daunizeau J, Dolan RJ, Friston KJ, Heinz A (2017) Computational neuroimaging strategies for single patient predictions. Neuroimage 145, 180–199. - PubMed
    1. Dirkx MF, Ouden den HEM, Aarts E, Timmer MHM, Bloem BR, Toni I, Helmich RC (2017) Dopamine controls Parkinson’s tremor by inhibiting the cerebellar thalamus. Brain 140,721–734. - PubMed

Publication types

MeSH terms